Programs

Presentations and Publications

Recent Presentations and Publications | Voxelotor Safety and Efficacy | Voxelotor Mechanism of Action | Selected Key Sickle Cell Disease Research | Selected Key Transcranial Doppler ResearchAdditional Sickle Cell Disease Research



Selected Key Sickle Cell Disease Research

Treating sickle cell disease by targeting HbS polymerization
Blood, Eaton and Bunn, May 2017

Sickle Cell Disease
New England Journal of Medicine, Piel et al, April 2017

Sickle cell disease: Its molecular mechanism and the one drug that treats it
International Journal of Biological Macromolecules, Ferrone F., December 2016

The delay time in sickle cell disease after 40 years: A paradigm assessed
American Journal of Hematology, Ferrone F., May 2015

Therapeutic Strategies to Alter the Oxygen Affinity of Sickle Hemoglobin
Hematology/Oncology Clinics of North America, Safo M. and Kato G., April 2014

Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin
British Journal of Haematology, Ngo et al, October 2011

Fetal hemoglobin in sickle cell anemia
Blood, Akinsheye et al, March 2011

Induction of Fetal Hemoglobin in Sickle Cell Disease
Blood, Bunn F., March 1999

Pathogenesis and Treatment of Sickle Cell Disease
New England Journal of Medicine, Bunn F., September 1997

Delay Time of Hemoglobin S Polymerization Prevents Most Cells from Sickling in Vivo
Science, Mozzarelli et al, July 1987